Hangzhou Tigermed Consulting Co., Ltd
300347
주식 순위
#3216
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides... Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People’s Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc. for innovative drugs, generic drugs, and medical devices, as well as supporting services directly related to clinical trials, including clinical operation, clinical trials, and clinical trials management. It also provides clinical trial related and laboratory services in the drug development process comprising data management and statistical analysis, clinical trial site management, subject recruitment, medical imaging, and laboratory services. In addition, the company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. Further, it provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People’s Republic of China.
주가
$7.44
시가총액
$5.49B
변동 (1일)
-2.99%
변동 (1년)
-0.42%
국가
CN
거래 Hangzhou Tigermed Consulting Co., Ltd (300347)
카테고리
Healthcare
Hangzhou Tigermed Consulting Co., Ltd (300347)의 주식 분할 이력
Hangzhou Tigermed Consulting Co., Ltd 주식 (심볼: 300347)은 총 4회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Jul 01, 2019에 발생했습니다.
May 02, 2013 이전에 매수한 300347 주식 1주는 현재 12주의 300347 주식에 해당합니다.
가장 최근의 분할은 Jul 01, 2019에 발생했습니다.
May 02, 2013 이전에 매수한 300347 주식 1주는 현재 12주의 300347 주식에 해당합니다.
주식 분할 목록
| 연도 | 주식 분할 | 배수 | 누적 배수 |
|---|---|---|---|
| 2019-07-01 | 3:2 | x1.5 | x12 |
| 2015-05-20 | 2:1 | x2 | x8 |
| 2014-04-22 | 2:1 | x2 | x4 |
| 2013-05-02 | 2:1 | x2 | x2 |
유사 기업 또는 경쟁사의 주식 분할
| 회사 | 주식 분할 횟수 | 누적 배수 | 국가 |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 1 | x100 |
BE
|
|
| 0 | - |
NL
|
